Synthesis of 6-methylaminopurine by thermal cyclization of 4,6-bis(methylamino)-5-phenylazopyrimidine

DOI: 10.1248/cpb.31.3454

Source and publish data:

Chemical and Pharmaceutical Bulletin p. 3454 - 3459 (1983)

Update date:2022-08-04

Topics:

Authors:

Mano Mano

Seo Seo

Imai Imai

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/cpb.31.3454

Full text of DOI:10.1248/cpb.31.3454

NII-Electronic Library Service

Products guided by the article

Product name:4,6-Pyrimidinediamine, N,N'-diethyl-5-(phenylazo)-

Cas No:89073-92-7

R&D Labs maybe for 89073-92-7

Melone Pharmaceutical Co., ltd

Contact:+86-411 82593920, 82593631

Address:No 232, JInma Roda, Development Zone, Dalian, China
Anhui New Star Pharmaceutical Development Co., Ltd

Contact:013956922763

Address:Floor 3, F9A, F Workshop, No.110 Kexue Road, High-Tech Development Zone, Hefei, Anhui ,China
Wuhan Sunrise Pharmaceutical Technology Co., Ltd

Contact:+86-27-83314682

Address:Room 340, New material Industrial base No.17, Gu Tian Five Lu , Qiaokou District, Wuhan , China
Lyrin Industrial Corporation Limited

Contact:86-731-82571800

Address:Rm 2408,Asia Economy International Building,Shaoshan Road South,Yuhua District,Changsha,Hunan,China
Hangzhou Zhenghan Biological Technology Co., Ltd.

Contact:86-571-88781753

Address:liangzhu yuhang hangzhou city

Relevant to this article

Synthesis of pentalenolactone E and F through biogenetic like cyclization of humulene

Doi:10.1016/S0040-4039(00)94293-X
(1983)
Bicyclic Lactam Inhibitors of Angiotensin Converting Enzyme

Doi:10.1021/jm00372a022
(1984)
A facile synthesis of substituted 1,8-naphthyridines based on the aza-Wittig/electrocyclic ring closure strategy

Doi:10.3987/COM-05-10629
(2006)
Discovery and SAR of Natural-Product-Inspired RXR Agonists with Heterodimer Selectivity to PPARδ-RXR

Doi:10.1021/acschembio.0c00146
(2020)
Reversible carbon-carbon bond formation between 1,3-dienes and aldehyde or ketone on nickel(0)

Doi:10.1021/ja060580l
(2006)
Discovery of sodium 6-[(5-chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]-2-pyridinecarboxylate (GSK269984A) an EP₁ receptor antagonist for the treatment of inflammatory pain

Doi:10.1016/j.bmcl.2009.02.112
(2009)

Article Doi